PHARMACY

NACDS shares update on formula shortage, Enfamil maker reportedly eyeing sale
The organization shared information with healthcare providers and parents in light of the infant formula shortage, and the maker of Enfamil is reportedly going forward with a sale of its business.
APhA analysis finds inequity in COVID-19 test to treat access
The analysis found that only 22% (513) of the test to treat sites are in the most vulnerable areas in the country as defined by the Social Vulnerability Index.

Food and pharmacy in one: What is the state of the supermarket pharmacy business?
Supermarket pharmacy executives weigh in on the health of their business and the industry as a whole.
Aurobindo receives FDA OK for generic Aromasin
Exemestane tablets have a market value of roughly $29 million for the 12 months ending March 2022, according to IQVIA.
CVS Health launches CVS Health Virtual Primary Care
CVS Health Virtual Primary Care will give members access to primary care, on-demand care, chronic condition management and mental health services virtually, with the option of being seen in person when needed.
Glenmark obtains FDA approval for generic Zytiga
Zytiga had a market value of roughly $260.2 million for the 12-month period ending March 2022, according to IQVIA.
Eli Lilly receives FDA green light for Mounjaro
Mounjaro is administered by injection under the skin once weekly, with the dose adjusted as tolerated to meet blood sugar goals.
Kendamil exporting infant formula to the US, select Abbott Nutrition formula to be available
Kendamil Nutricare said it expects to meet the needs of at least 150,000 U.S. households during the import period, and certain Abbott Nutrition formulas will be available on a case-by-case basis.
Retailers are expanding COVID-19 vaccines, antiviral and test availability
In response to the lingering COVID-19 pandemic, retailers, including Hy-Vee, Rite Aid, Kroger, Wegmans and H-E-B, are expanding COVID-19 vaccinations to adults and children, antiviral medications and COVID-19 tests.
AAM elevates Craig Burton
Burton was named AAM senior vice president of policy and strategic alliances, and executive director of the Biosimilars Council.
NCPA supports Senate bill empowering FTC action against PBMs
The Cantwell/Grassley bill will enable the FTC and state attorneys general to have enforcement authority against PBMs.
Amber Specialty Pharmacy added to Eisai’s Lenvima network
Amber Specialty Pharmacy will dispense Lenvima for certain types of cancer.
Camber intros generic Atripla
The product is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients.
Kinney Drugs named Business of the Year
Kinney Drugs and its employees were honored for consistently giving back by supporting and raising money for local events and charities, but also for the pharmacy chain’s quick and meaningful actions during the height of the pandemic.

News and information on retail pharmacy, including generic drugs, branded drugs, specialty pharmacy medications, pharmacy technology and legislative updates.